EU, Germany inject €415,000 into Ghana's pharmaceutical manufacturing drive
The European Union (EU) and the German Ministry for Economic Cooperation and Development have formalized a €415,437.78 grant to launch the PharmaVax Programme. This initiative is designed to overhaul structural deficiencies in Ghana's pharmaceutical landscape and propel the nation toward becoming the primary manufacturing hub for the sub-region. The program is structured around a four-pillar framework, seeking to fortify regulatory governance, foster deeper synergy between the state and private stakeholders, streamline foreign direct investment, and digitize transparency in licensing and authorization processes.
Mr. Yaw Sakyi, Director of Administration at the Ministry of Trade and Agribusiness, reiterated the government's commitment to weaning the country off its heavy reliance on imported medicines. He stated, "The pharmaceutical policy will provide the necessary implementation systems for the growth of the industry." Mr. Godfred Gobah, Head of the Pharmaceutical Manufacturing Development Unit, noted that the government is moving beyond policy to active market facilitation, with clear targets set for the year 2030. The Ministry is preparing a series of strategic interventions to boost the visibility of "Made in Ghana" medicines on the international stage.
Quick Summary
The EU and Germany have provided a significant grant to Ghana to launch the PharmaVax Programme, aiming to transform the nation's pharmaceutical
Summary - read the full story for complete context.

Image: MyJoyOnline
GhanaFront aggregates news from trusted sources. Click to read the original article.
Keywords
Explore related tagsMore from MyJoyOnline
Related Stories
More from Business & Economy

Mahama administration boosts Ghana's gold reserves to $13.8bn - Sammy Gyamfi
Ghana's gold reserves are a hot topic, with new information shedding light on the government's strategic moves in the gold sector.
2d ago•










